Designed to increase the efficiency and quality of vaccine discovery, the end-to-end enterprise platform supports the full development process for novel vaccines and enables faster testing, simplified production, and reduced costs.
QbD. Clone selection. Media optimization. CQA monitoring. Optimizing DSP unit operations. Formulation screening. Genedata Bioprocess® offers purpose-built functionalities to reduce timelines across cell line development, upstream and downstream process development, formulation, and analytical development.